| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.023 | 0.9 |